A prospective study of hepatitis C virus infection in renal allograft recipients

Transplantation

Volumn 61, Issue 6, 1996, Pages 886-889

  Roth, David ^a,b   Zucker, Keith ^a   Cirocco, Robert ^a   Burke, George ^a   Ciancio, Gaetano ^a   Esquenazi, Violet ^a   Swanson III, Sidney J ^a,c   Miller, Joshua ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Department of Medicine ^*  (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; INFECTION RISK; KIDNEY ALLOGRAFT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL;

ADULT; BIOPSY; FOLLOW-UP STUDIES; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVER; MIDDLE AGED; PROSPECTIVE STUDIES; TACROLIMUS; TREATMENT OUTCOME;

EID: 0029887721     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199603270-00007     Document Type: Article

References (27)

1. Kuo G, Choo Q-L, Alter, HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362.
2. Alter HJ, Purcell RH, Shih JW, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989; 321: 1494.
3. Morales M, Campo C, Castellano G, et al. Clinical implications of the presence of antibodies to hepatitis C after renal transplantation. Transplant Proc 1992; 24: 78.
4. Pol S, Legendre C, Saltiel C, et al. Hepatitis C virus in kidney recipients. J Hepatol 1992; 15: 202.
5. Roth D. Hepatitis C virus: The nephrologists view. Am J Kidney Dis 1995; 23: 3.
6. Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332: 1463.
7. Kiyosawa K, Sodeyama T, Tanaka E, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671.
8. Koretz RL, Abbey H, Coleman E, Gitnick G. Non-A, non-B post-transfusion hepatitis: looking back in the second decade. Ann Intern Med 1993; 119: 110.
9. Seeff LB, Buskell-Bales Z, Wright EC, et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 1992; 327: 1906.
10. Roth D, Zucker K, Cirocco R, et al. The impact of hepatitis C virus infection on renal allograft recipients. Kidney Int 1994; 45: 238.
11. Ponz E, Campistol JM, Brugeura M, et al. Hepatitis C virus infection among kidney transplant recipients. Kidney Int 1991; 40: 748.
12. Baur P, Daniel V, Pomer S, Scheulen H, Opelz G, Roelcke D. Hepatitis C virus antibodies in patients after kidney transplantation. Ann Hematol 1991; 62: 68.
13. Klauser R, Franz O, Traindl O, et al. Hepatitis C antibody in renal transplant patients. Transplant Proc 1992; 24: 286.
14. Stempel CA, Lake J, Kuo G, Vincenti F. Hepatitis C - its prevalence in end-stage renal failure patients and clinical course after kidney transplantation. Transplantation 1993; 55: 273.
15. Huang C-C, Liaw Y-F, Lai M-K, Chu S-H, Chuang C-K, Huang J-Y. The clinical outcome of hepatitis C virus antibody-positive renal allograft recipients. Transplantation 1992; 53: 763.
16. Stuyver L, Rossau R, Wyseur A, et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993; 74: 1093.
17. Lau J, Davis GL, Brunson ME, et al. Hepatitis C virus infection in kidney transplant recipients. Hepatology 1993; 18; 1027.
18. Lim HL, Lau GK, Davis G, Dolson DJ, Lau J. Cholestatic hepatitis leading to hepatic failure in a patient with organ-transmitted hepatitis C virus infection. Gastroenterology 1994; 106: 248.
19. Krops A, deMan R, Niestees H, Schalm S, Weimar W, Balk A. Fatal hepatitis C virus infection in a heart transplant recipient detectable by polymerase chain reaction only. J Hepatol 1994; 21: 1113.
20. Meshari KA, Shaibani KA, Alfurayh O, Qunib WY, Ali MA. Kidney transplantation in HCV infected hemodialysis patients with mild hepatitis: a prospective controlled study of liver disease and graft function. J Am Soc Nephrol 1994; 5: 993.
21. Honda M, Kaneko S, Sakai A, Unoura M, Murakami S, Kobayashi K. Degree of diversity of hepatitis C virus quasispecies and progression of disease. Hepatology 1994; 20: 1144.
22. Simmonds P. Variability of hepatitis C virus. Hepatology 1995; 21: 570.
23. Martin P. Hepatic C genotypes: The key to pathogenicity? Ann Intern Med 1995; 122: 227.
24. Weir MR, Kirkman RL, Strom TB, Tilney NL. Liver disease in recipients of long-functioning renal allografts. Kidney Int 1985; 28: 839.
25. Kirkman RL, Strom TB, Weir MR, Tilney NL. Late mortality and morbidity in recipients of long-term renal allografts. Transplantation 1982; 34: 347.
26. Rao KV, Anderson RC. Long-term results and complications in renal transplant recipients. Transplantation 1988; 45: 45.
27. Rao KV, Anderson WR, Kasiske BL. Value of liver biopsy in the evaluation and management of chronic liver disease in renal transplant recipients. Am J Med 1993; 94: 241.